Overview

Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)

Status:
Not yet recruiting

Trial end date:
2029-04-30

Target enrollment:

Participant gender:

Summary

This phase II study is a prospective, multi-center, double-blinded, and randomized trial to compare the efficacy and safety of perioperative SOX plus serplulimab with SOX plus placebo for locally advanced gastric adenocarcinoma with proficient mismatch repair

Phase:

Phase 2

Details

Lead Sponsor:

Yu jiren

Treatments:

Oxaliplatin